← Open Payments lookup

JOSE MENDEZ: Open Payments

NPI 1912195017 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$863 in 33 payments from 11 companies in 2025. Trend: 2023 $1,644 · 2024 $811 · 2025 $863

Food & beverage: $863
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$167
E.R. Squibb & Sons, L.L.C.7$160
ABBVIE INC.7$139
Axsome Therapeutics, Inc.4$105
Alkermes, Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$78
Janssen Pharmaceuticals, Inc1$36
Takeda Pharmaceuticals U.S.A., Inc.1$27
Tris Pharma Inc1$23
Bausch Health US, LLC1$20

Products named: INGREZZA, COBENFY, VRAYLAR, CAPLYTA, Auvelity, Sunosi, LYBALVI, INVEGA SUSTENNA.

Industry payments across FL — which companies pay providers there.